Cet anticorps anti-VEGFR2/CD309 Polyclonal Lapin (ABIN362632) détecte spécifiquement VEGFR2/CD309 dans IHC et IF.
L’anticorps est réactif avec des échantillons de Humain, Souris et Rat.
The antibody detects endogenous level of total VEGFR2 protein.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
Immunogène
Peptide sequence around AA 1212-1216 (F-H-Y-D-N) derived from Human VEGFR2. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C/-20 °C
Stockage commentaire
Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
Antigène
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Autre désignation
VEGFR2
Sujet
Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions